The European Medicines Agency Ema has recommended
granting an extension of the indication for Pfizer-BioNtech's Covid vaccine to include use for children aged 5 to 11 years
.
The vaccine is already approved for use in adults and children aged 12 and over.
It reads in a note from the EMA.
The Scientific Technical Commission of the Italian Medicines Agency was convened next week, from 1 to 3 December, with the evaluation of the EMA ruling on anti-Covid vaccination for the pediatric age group 5-11 on the agenda. years.
Meanwhile, according to a circular from the Ministry of Health published today, starting from 1 December 2021 "it
is recommended to administer a dose of mRNA vaccine, as a booster of a primary vaccination cycle, even to subjects equal to or older than 18 years, in the dosages authorized for the purpose, regardless of the vaccine used for the primary cycle and provided that a minimum interval of at least five months
(150 days) has elapsed from the completion of the same ".